Search results for "Crossover study"

showing 10 items of 161 documents

Ecological momentary assessment for chronic pain in fibromyalgia using a smartphone: A randomized crossover study

2013

Background Daily diaries are a useful way of measuring fluctuations in pain-related symptoms. However, traditional diaries do not assure the gathering of data in real time, not solving the problem of retrospective assessment. Ecological momentary assessment (EMA) by means of electronic diaries helps to improve repeated assessment. However, it is important to test its feasibility in specific populations in order to reach a wider number of people who could benefit from these procedures. Methods The present study compares the compliance and acceptability of an electronic diary running on a smartphone using a crossover design for a sample with a specific pain condition, fibromyalgia and low fam…

EcologyMEDLINEChronic painSample (statistics)medicine.diseaseCrossover studylaw.inventionTest (assessment)Anesthesiology and Pain MedicineRandomized controlled triallawFibromyalgiaPublic hospitalmedicineInformationSystems_MISCELLANEOUSPsychologyEuropean Journal of Pain
researchProduct

The Limits of Ego Depletion

2019

Abstract. Evidence on the existence of the ego depletion phenomena as well as the size of the effects and potential moderators and mediators are ambiguous. Building on a crossover design that enables superior statistical power within a single study, we investigated the robustness of the ego depletion effect between and within subjects and moderating and mediating influences of the ego depletion manipulation checks. Our results, based on a sample of 187 participants, demonstrated that (a) the between- and within-subject ego depletion effects only had negligible effect sizes and that there was (b) large interindividual variability that (c) could not be explained by differences in ego depleti…

Ego depletionSociology and Political ScienceSocial Psychologymedia_common.quotation_subject05 social sciences050109 social psychologySelf-controlCrossover study050105 experimental psychologyStatistical powerTask (project management)Arts and Humanities (miscellaneous)Robustness (computer science)Id ego and super-ego0501 psychology and cognitive sciencesPsychologySocial psychologyGeneral Psychologymedia_commonCognitive psychologySocial Psychology
researchProduct

Cardiovascular effect of dental anesthesia with articaine (40 mg with epinefrine 0,5 mg % and 40 mg with epinefrine 1 mg%) versus mepivacaine (30 mg …

2011

Objectives: The aim of the present study is to compare cardiovascular safety profiles of two dental anesthetics: articaine versus two standard mepivacaine solutions used during etiological periodontal treatment in cardiovascular patients. Study Design: Using a cross-over study design, ten cardiovascular patients were randomly assigned to dental treatment with 1.8mL of a local anesthetic injected on each quadrant of the mouth: Articaine (40mg with Epinephrine 0.5mg % and 40mg with Epinephrine 1mg %) or Mepivacaine (30mg and 20mg with Epinephrine 1mg %). A computer programme enabled continuous longitudinal data collection: O2 saturation, blood pressure (BP) and heart rate (HR). Results: No se…

Epinephrinemedicine.drug_classAnesthesia DentalMepivacaineBlood PressureCarticaineArticaineDrug toxicityCarticaineDental anesthesiaHeart RatemedicineHumansVasoconstrictor AgentsSingle-Blind MethodProspective StudiesAnesthetics LocalGeneral DentistryCross-Over StudiesLocal anestheticbusiness.industryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Crossover studyAnesthetics CombinedDental anesthesiaCardiovascular diseasesEpinephrineBlood pressureOtorhinolaryngologyCardiovascular DiseasesAnesthesiaUNESCO::CIENCIAS MÉDICASMepivacaineChronic periodontitisResearch-ArticleSurgerybusinessPtes Especiales and Bioengineering in Dentistrymedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial

2012

    In a prospective, multicenter, open-label study, de novo liver transplant patients were randomized at day 30±5 to (i) everolimus initiation with tacrolimus elimination (TAC Elimination) (ii) everolimus initiation with reduced-exposure tacrolimus (EVR+Reduced TAC) or (iii) standard-exposure tacrolimus (TAC Control). Randomization to TAC Elimination was terminated prematurely due to a higher rate of treated biopsy-proven acute rejection (tBPAR). EVR+Reduced TAC was noninferior to TAC Control for the primary efficacy endpoint (tBPAR, graft loss or death at 12 months posttransplantation): 6.7% versus 9.7% (-3.0%; 95% CI -8.7, 2.6%; p<0.001 for noninferiority [12% margin]). tBPAR occurred in…

Graft RejectionCHRONIC KIDNEY-DISEASEMaleTime Factorsmedicine.medical_treatmentMedizinKaplan-Meier EstimateLiver transplantationKidneyKidney Function TestsGLOMERULAR-FILTRATION-RATEImmunosuppressive AgentHEPATOCELLULAR-CARCINOMASIROLIMUS-BASED IMMUNOSUPPRESSIONImmunology and AllergySirolimuPharmacology (medical)Prospective StudiestacrolimusMYCOPHENOLATE-MOFETILCOMPLICATIONSCross-Over Studiesliver transplantationwithdrawalGraft SurvivalCross-Over StudieMiddle AgedTreatment Outcomesurgical procedures operativeSurvival AnalysireducedLife Sciences & BiomedicineImmunosuppressive AgentsHumanGlomerular Filtration Ratemedicine.drugAdultmedicine.medical_specialtyRandomizationTime FactorAdolescentEfficacyUrologyRenal functionchemical and pharmacologic phenomenaCALCINEURIN INHIBITORRisk AssessmentDrug Administration ScheduleFollow-Up StudieYoung Adultstomatognathic systemTransplantation ImmunologyDOSE TACROLIMUSConfidence IntervalsmedicineHumansMETAANALYSISAgedSirolimusTransplantationKidney Function TestScience & TechnologyEverolimusDose-Response Relationship Drugbusiness.industryeverolimutacrolimuOriginal ArticleseverolimusSurvival AnalysisCrossover studyTacrolimusSurgeryTransplantationProspective StudieCONVERSIONstomatognathic diseasesSirolimusSurgerybusinessConfidence IntervalLiver FailureFollow-Up StudiesAmerican Journal of Transplantation
researchProduct

Effects of bovine colostrum supplementation on serum IGF-I, IgG, hormone, and saliva IgA during training.

1997

Mero, Antti, Heidi Miikkulainen, Jarmo Riski, Raimo Pakkanen, Jouni Aalto, and Timo Takala. Effects of bovine colostrum supplementation on serum IGF-I, IgG, hormone, and saliva IgA during training. J. Appl. Physiol.83(4): 1144–1151, 1997.—The purpose of this study was to examine the effects of bovine colostrum supplementation (Bioenervi) on serum insulin-like growth factor I (IGF-I), immunoglobulin G, hormone, and amino acid and saliva immunoglobulin A concentrations during a strength and speed training period. Nine male sprinters and jumpers underwent three randomized experimental training treatments of 8 days separated by 13 days. The only difference in the treatments was the drink of 125…

Immunoglobulin AAdultMalemedicine.medical_specialtySalivaPhysiologymedicine.medical_treatmentPlaceboImmunoglobulin GDouble-Blind MethodPhysiology (medical)Internal medicineMedicineAnimalsHumansNutritional Physiological PhenomenaInsulin-Like Growth Factor ISalivaCross-Over Studiesbiologybusiness.industryInsulinColostrumTrack and FieldCrossover studyHormonesImmunoglobulin AEndocrinologyPhysical FitnessImmunoglobulin Gbiology.proteinColostrumCattlebusinessHormoneJournal of applied physiology (Bethesda, Md. : 1985)
researchProduct

Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabe…

2019

The aim of the study was to assess the amount of orally administered carbohydrates needed to maintain euglycemia during moderate-intensity exercise in individuals with type 1 diabetes. Nine participants with type 1 diabetes (four women, age 32.1 &plusmn

Insulin degludecAdultBlood GlucoseMalemedicine.medical_specialtyinsulintype 1 diabetesmedicine.medical_treatmentcarbohydratesBlood sugar030209 endocrinology & metabolismPhysical exerciselcsh:TX341-641Article03 medical and health sciencesYoung Adult0302 clinical medicineOxygen ConsumptionInternal medicineDiabetes mellitusmedicineDietary CarbohydratesHumansType 1 diabetesNutrition and DieteticsCross-Over Studiesexercisebusiness.industryInsulin030229 sport sciencesmedicine.diseaseCrossover studyHypoglycemiaBicyclingEndocrinologyDiabetes Mellitus Type 1Blood chemistryFemaleeuglycemiabusinesslcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized c…

2018

Aims To compare the time spent in specified glycaemic ranges in people with type 1 diabetes (T1D) during 5 consecutive days of moderate-intensity exercise while on either 100% or 75% of their usual insulin degludec (IDeg) dose. Materials and methods Nine participants with T1D (four women, mean age 32.1 ± 9.0 years, body mass index 25.5 ± 3.8 kg/m2 , glycated haemoglobin 55 ± 7 mmol/mol (7.2% ± 0.6%) on IDeg were enrolled in the trial. Three days before the first exercise period, participants were randomized to either 100% or 75% of their usual IDeg dose. Participants exercised on a cycle ergometer for 55 minutes at a moderate intensity for 5 consecutive days. After a 4-week wash-out period,…

Insulin degludecType 1 diabetesbusiness.industryEndocrinology Diabetes and MetabolismArea under the curve030209 endocrinology & metabolism030204 cardiovascular system & hematologymedicine.diseaseCrossover study03 medical and health sciences0302 clinical medicineEndocrinologyRegular exerciseAnesthesiaInternal MedicineMedicineAnalysis of varianceDosingbusinessBody mass index
researchProduct

The effect of orally administered probiotic Lactobacillus reuteri -containing tablets in peri-implant mucositis: a double-blind randomized controlled…

2015

Background and Objectives Probiotics create a biofilm and protect the oral tissues against the action of periodontal pathogenic bacteria. The aim of this study was to evaluate the effects of the oral probiotic Lactobacillus reuteri Prodentis upon the peri-implant health of edentulous patients with dental implants and peri-implant mucositis, establishing comparisons vs implants without peri-implant disease. Material and Methods A double-blind, placebo-controlled, prospective cross-over study was made. The patients were all edentulous and were divided into two groups, (A) no peri-implant disease, and (B) peri-implant mucositis affecting one or more implants. Patients with peri-implantitis wer…

Limosilactobacillus reuteriMaleMucositismedicine.medical_specialtyPeri-implant mucositisDentistryPlaceboGastroenterologylaw.inventionPlacebosProbioticDouble-Blind MethodRandomized controlled triallawInternal medicinemedicineMucositisHumansProspective StudiesProspective cohort studyAgedCross-Over Studiesbiologybusiness.industryProbioticsMiddle Agedmedicine.diseasebiology.organism_classificationCrossover studyLactobacillus reuteriDental ImplantationTreatment OutcomeCytokinesPeriodonticsFemalebusinessTabletsJournal of Periodontal Research
researchProduct

Bupivacaine 0.5% versus articaine 4% for the removal of lower third molars. A crossover randomized controlled trial.

2012

Objective: To compare the anesthetic action of 0.5% bupivacaine in relation to 4% articaine, both with 1:200,000 epinephrine, in the surgical removal of lower third molars. As a secondary objective hemodynamic changes using both anesthetics were analyzed. Study Design: Triple-blind crossover randomized clinical trial. Eighteen patients underwent bilateral removal of impacted lower third molars using 0.5% bupivacaine or 4% articaine in two different appointments. Preoperative, intraoperative and postoperative variables were recorded. Differences were assessed with McNemar tests and repeated measures ANOVA tests. Results: Both solutions exhibited similar latency times and intraoperative effic…

Local anesthesiaAdultMalemedicine.medical_specialtyAnestèsia en odontologiaAdolescentHemodynamicsCarticaineArticainelaw.inventionPostoperative painYoung AdultDolor postoperatoriClinical trialsRandomized controlled trialDouble-Blind MethodlawMedicineTeeth extractionHumansAnesthetics LocalGeneral DentistryExtracció dentalBupivacaineCross-Over Studiesbusiness.industryRepeated measures designAnestèsia localDent molar:CIENCIAS MÉDICAS [UNESCO]Crossover studyMolarBupivacaineSurgeryBlood pressureOtorhinolaryngologyAnesthesiaAnestheticUNESCO::CIENCIAS MÉDICASTooth ExtractionSurgeryFemaleMolar ThirdResearch-ArticleAnesthesia in dentistryOral Surgerybusinessmedicine.drugAssaigs clínicsMedicina oral, patologia oral y cirugia bucal
researchProduct

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

2017

Prevenció; Atac d'angioedema; Inhibidor C1 Prevención; Ataque de angioedema; Inhibidor C1 Prevention; Angioedema attack; C1 inhibitor BACKGROUND: Hereditary angioedema is a disabling, potentially fatal condition caused by deficiency (type I) or dysfunction (type II) of the C1 inhibitor protein. In a phase 2 trial, the use of CSL830, a nanofiltered C1 inhibitor preparation that is suitable for subcutaneous injection, resulted in functional levels of C1 inhibitor activity that would be expected to provide effective prophylaxis of attacks. METHODS: We conducted an international, prospective, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase 3 trial to evaluate the …

Male:aminoácidos péptidos y proteínas::péptidos::serpinas::proteínas inactivadoras del complemento C1::proteína inhibidora del complemento C1 [COMPUESTOS QUÍMICOS Y DROGAS]0301 basic medicine:Otros calificadores::Otros calificadores::/prevención & control [Otros calificadores]Enzims proteolítics - InhibidorsSelf AdministrationSeverity of Illness Indexlaw.inventionC1-inhibitorSubcutaneous injection0302 clinical medicineRandomized controlled triallawCross-Over StudiesHereditary Angioedema Types I and IIbiologyEdema - PrevencióGeneral Medicine:Cardiovascular Diseases::Vascular Diseases::Angioedema::Angioedemas Hereditary [DISEASES]AnesthesiaHereditary angioedema:Other subheadings::Other subheadings::/administration & dosage [Other subheadings]Female:Amino Acids Peptides and Proteins::Peptides::Serpins::Complement C1 Inactivator Proteins::Complement C1 Inhibitor Protein [CHEMICALS AND DRUGS]medicine.symptomComplement C1 Inhibitor Protein:enfermedades cardiovasculares::enfermedades vasculares::angioedema::angioedemas hereditarios [ENFERMEDADES]AdultRiskmedicine.medical_specialtyInjections Subcutaneous:Aminoácidos Péptidos y Proteínas::Péptidos::Serpinas::Proteínas Inactivadoras del Complemento 1::Proteína Inhibidora del Complemento C1 [COMPUESTOS QUÍMICOS Y DROGAS]Placebo:Other subheadings::Other subheadings::/prevention & control [Other subheadings]03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumans:Therapeutics::Drug Therapy::Drug Administration Routes::Injections::Injections Subcutaneous [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]:Otros calificadores::Otros calificadores::/administración & dosificación [Otros calificadores]Dose-Response Relationship DrugAngioedemabusiness.industry:Terapéutica::Tratamiento Farmacológico::Vías de Administración de Medicamentos::Inyecciones::Inyecciones Subcutáneas [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]Injeccions hipodèrmiquesmedicine.diseaseCrossover studyClinical trial:terapéutica::farmacoterapia::vías de administración de medicamentos::inyecciones::inyecciones subcutáneas [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]030104 developmental biology030228 respiratory systembiology.proteinbusinessNew England Journal of Medicine
researchProduct